Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/44440
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBidakhvidi, Niloefar Ahmadi-
dc.contributor.authorGevaert, Thomas-
dc.contributor.authorDe Schepper, Maxim-
dc.contributor.authorBaldewijns, Marcella-
dc.contributor.authorHavinga, Enrique-
dc.contributor.authorDeckers, Wies-
dc.contributor.authorLAENEN, Annouschka-
dc.contributor.authorDevos, Gaetan-
dc.contributor.authorGiesen, Alexander-
dc.contributor.authorJoniau, Steven-
dc.contributor.authorKoole, Michel-
dc.contributor.authorEveraerts, Wouter-
dc.contributor.authorDeroose, Christophe M.-
dc.contributor.authorGoffin, Karolien-
dc.date.accessioned2024-10-08T09:48:47Z-
dc.date.available2024-10-08T09:48:47Z-
dc.date.issued2024-
dc.date.submitted2024-10-07T14:00:45Z-
dc.identifier.citationEuropean journal of nuclear medicine and molecular imaging (Print),-
dc.identifier.urihttp://hdl.handle.net/1942/44440-
dc.description.abstractPurpose Quantification of PSMA expression via PSMA PET is well-established, however quantification of PSMA via immunohistochemistry (IHC) is not standardized. Our aim was to determine the most optimal PSMA IHC scoring system to quantify PSMA expression with PSMA PET as reference standard. Methods Primary intermediate- and high-risk prostate cancer patients received an [F-18]PSMA-1007 PET/MRI followed by radical prostatectomy. SUVmax, SUVmean and K-i of the prostate tumor was determined. Prostate tumors were stained with anti-PSMA antibodies and scored by 2 readers via 10 IHC scoring systems: histochemical score (H-score), immunoreactivity score(predominant intensity) (IRSpredominant intensity), IRS classification(predominant intensity), IRSmean intensity, IRS classification(mean intensity), Allred score, predominant expression pattern, Shannon diversity index (SDI), percentage negatively stained cells and total percentage positively stained cells. Spearman's rank correlation coefficients (rho) were calculated between PET parameters and IHC scoring systems. Interreader agreement for the IHC scoring systems was measured by the intraclass correlation coefficient (ICC). Results Fifty tumors in 46 patients were analysed. H-score had the best correlation with SUVmax (rho 0.615 p < 0.0001) and SUVmean (rho 0.570, p < 0.0001) and the second best correlation with Ki (rho 0.411, p = 0.0030). SDI had the best correlation with Ki (rho -0.440, p = 0.0014) and the second best correlation with SUVmax (rho -0.516, p = 0.0001) and SUVmean (rho -0.490, p = 0.0003). A moderate interreader agreement was observed for H-score (ICC 0.663, 95% CI 0.495-0.797) and SDI (ICC 0.546, 95% CI 0.354-0.725). Conclusion H-score had the best correlation with PSMA PET quantification and an acceptable interreader agreement. Therefore, we deem H-score the most optimal PSMA IHC scoring system.-
dc.description.sponsorshipFunding This work was supported by the Agency for Innovation By Science and Technology (IWT, grant number IWT.140193). Acknowledgements The authors are grateful to the study participants and to Kwinten Porters, Jef Van Loock, Stefan Ghysels, Kris Byloos and Guido Putzeys for their contribution to the scanning and data handling, and to Kathleen Van den Eynde, Nele Crama, Sabrina D’Haese and Sofie De Block for their contribution to the processing of the pathology specimens. Steven Joniau, Wouter Everaerts, Christophe M. Deroose are senior clinical investigators at the Research FoundationFlanders (FWO). Niloefar Ahmadi Bidakhvidi is a PhD fellow at the Research Foundation-Flanders (FWO).-
dc.language.isoen-
dc.publisherSPRINGER-
dc.rightsThe Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2024.-
dc.subject.otherPSMA PET-
dc.subject.otherPSMA immunohistochemistry-
dc.subject.otherPET/MR-
dc.subject.otherParametric PET-
dc.subject.otherPrimary prostate cancer-
dc.titleComparison of PSMA immunohistochemistry scoring systems to parametric [18F]PSMA-1007 PET/MRI in primary prostate cancer-
dc.typeJournal Contribution-
local.format.pages13-
local.bibliographicCitation.jcatA1-
dc.description.notesGoffin, K (corresponding author), Univ Hosp Leuven, Nucl Med, Leuven, Belgium.; Goffin, K (corresponding author), Katholieke Univ Leuven, Dept Imaging & Pathol, Nucl Med & Mol Imaging, Leuven, Belgium.-
dc.description.noteskarolien.goffin@uzleuven.be-
local.publisher.placeONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES-
local.type.refereedRefereed-
local.type.specifiedArticle-
local.bibliographicCitation.statusEarly view-
dc.identifier.doi10.1007/s00259-024-06903-7-
dc.identifier.pmid39269656-
dc.identifier.isi001312295900001-
dc.contributor.orcidDevos, Gaetan/0000-0002-6772-915X; joniau, steven/0000-0003-3195-9890;-
dc.contributor.orcidLaenen, Annouschka/0000-0002-1371-442X; Deroose,-
dc.contributor.orcidChristophe/0000-0002-6080-1577; Giesen, Alexander/0000-0002-3345-4573;-
dc.contributor.orcidAhmadi Bidakhvidi, Niloefar/0000-0002-2225-0161; Everaerts,-
dc.contributor.orcidWouter/0000-0002-3157-7115; Baldewijns, Marcella/0000-0002-0882-2944-
local.provider.typewosris-
local.description.affiliation[Bidakhvidi, Niloefar Ahmadi; Deckers, Wies; Koole, Michel; Deroose, Christophe M.; Goffin, Karolien] Univ Hosp Leuven, Nucl Med, Leuven, Belgium.-
local.description.affiliation[Bidakhvidi, Niloefar Ahmadi; Koole, Michel; Deroose, Christophe M.; Goffin, Karolien] Katholieke Univ Leuven, Dept Imaging & Pathol, Nucl Med & Mol Imaging, Leuven, Belgium.-
local.description.affiliation[Gevaert, Thomas; Devos, Gaetan; Giesen, Alexander; Joniau, Steven] Katholieke Univ Leuven, Dept Dev & Regenerat, Urogenital Abdominal & Plast Surg, Leuven, Belgium.-
local.description.affiliation[De Schepper, Maxim; Baldewijns, Marcella] Univ Hosp Leuven, Pathol, Leuven, Belgium.-
local.description.affiliation[Havinga, Enrique] Univ Hosp Leuven, Radiol, Leuven, Belgium.-
local.description.affiliation[Laenen, Annouschka] Interuniv Inst Biostat & Stat Bioinformat, Leuven, Belgium.-
local.description.affiliation[Devos, Gaetan; Giesen, Alexander; Joniau, Steven; Everaerts, Wouter] Univ Hosp Leuven, Urol, Leuven, Belgium.-
local.description.affiliation[Everaerts, Wouter] Katholieke Univ Leuven, Lab Ion Channel Res, Dept Cellular & Mol Med, Leuven, Belgium.-
local.uhasselt.internationalno-
item.fullcitationBidakhvidi, Niloefar Ahmadi; Gevaert, Thomas; De Schepper, Maxim; Baldewijns, Marcella; Havinga, Enrique; Deckers, Wies; LAENEN, Annouschka; Devos, Gaetan; Giesen, Alexander; Joniau, Steven; Koole, Michel; Everaerts, Wouter; Deroose, Christophe M. & Goffin, Karolien (2024) Comparison of PSMA immunohistochemistry scoring systems to parametric [18F]PSMA-1007 PET/MRI in primary prostate cancer. In: European journal of nuclear medicine and molecular imaging (Print),.-
item.fulltextWith Fulltext-
item.accessRightsRestricted Access-
item.contributorBidakhvidi, Niloefar Ahmadi-
item.contributorGevaert, Thomas-
item.contributorDe Schepper, Maxim-
item.contributorBaldewijns, Marcella-
item.contributorHavinga, Enrique-
item.contributorDeckers, Wies-
item.contributorLAENEN, Annouschka-
item.contributorDevos, Gaetan-
item.contributorGiesen, Alexander-
item.contributorJoniau, Steven-
item.contributorKoole, Michel-
item.contributorEveraerts, Wouter-
item.contributorDeroose, Christophe M.-
item.contributorGoffin, Karolien-
crisitem.journal.issn1619-7070-
crisitem.journal.eissn1619-7089-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
s00259-024-06903-7.pdf
  Restricted Access
Early view1.58 MBAdobe PDFView/Open    Request a copy
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.